Nicotine-induced conditioned place preference in adolescent and adult rats

Physiology and Behavior

Volumn 77, Issue 1, 2002, Pages 107-114

  Vastola, Bonnie J ^a   Douglas, Lewis A ^a   Varlinskaya, Elena I ^a   Spear, Linda P ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Adolescence; Conditioned place preference; Locomotor activity; Nicotine; Sprague Dawley rats; Stimulatory effects

Indexed keywords

NICOTINE;

ADOLESCENCE; ADOLESCENT; AGE; AGED; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; LONG TERM EXPOSURE; MOTOR ACTIVITY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

EID: 0036711037     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(02)00818-1     Document Type: Article

References (61)

1. Johnston L.D., O'Malley P.M., Bachman J.G. Secondary school students. National survey results on drug use from the monitoring the future study, 1975-1997. vol. 1:1998;National Institute on Drug Abuse, Washington (DC).
2. Alexander C., Piazza M., Mekos D., Valente T. Peers, schools, and adolescent cigarette smoking. J Adolesc Health. 29:2001;22-30.
3. Wang M.Q., Fitzhugh E.C., Green B.L., Turner L.W., Eddy J.M., Westerfield R.C. Prospective social-psychological factors of adolescent smoking progression. J Adolesc Health. 24:1999;2-9.
4. Chen J., Millar W.J. Age of smoking initiation: implications for quitting. Health Rep. 9:1998;39-46.
5. Nelson D.E., Giovino G.A., Shopland D.R., Mowery P.D., Mills S.L., Eriksen M.P. Trends in cigarette smoking among US adolescents, 1974 through 1991. Am J Public Health. 85:1995;34-40.
6. Pierce J.P., Gilpin E. How long will today's new adolescent smoker be addicted to cigarettes? Am J Public Health. 86:1996;253-256.
7. Taoli E., Wydner E.L. Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med. 325:1991;968-969.
8. Colby S.M., Tiffany S.T., Shiffman S., Niaura R. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend. 59(Suppl. 1):2000;S83-S95.
9. Kandel D.B., Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res. 2:2000;263-274.
10. Di Chiara G. Behavioural pharmacology and neurobiology of nicotine reward and dependence. Clementi F., Fornasari D., Gotti C. Handbook of experimental pharmacology. vol. 144:2000;603-750 Springer, Heidelberg.
11. Clarke P.B.S., Fu D.S., Jacubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther. 246:1988;701-708.
12. Corrigall W.A., Franklin K.J.B., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
13. Corrigall W.A., Coen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental aria. Brain Res. 653:1994;278-284.
14. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 24:2000;417-463.
15. Jernigan T.L., Trauner D.A., Hesselink J.R., Tallal P.A. Maturation of human cerebrum observed in vivo during adolescence. Brain. 114:1991;2037-2049.
16. Zecevic N., Bourgeois J-P, Rakic P. Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal life. Dev Brain Res. 50:1989;11-32.
17. Insel T.R., Miller L.P., Gelhard R.E. The ontogeny of excitatory amino acid receptors in rat forebrain: I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience. 35:1990;31-43.
18. Rosenberg D.R., Lewis D.A. Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: a tyrosine hydroxylase immunohistochemical study. Biol Psychiatry. 36:1994;272-277.
19. Rosenberg D.R., Lewis D.A. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol. 358:1995;383-400.
20. Kalsbeek A., Voorn P., Buijs R.M., Pool C.W., Uylings H.B.M. Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol. 269:1988;58-72.
21. Leslie C.A., Robertson M.W., Cutler A.J., Bennett J.P. Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis. Dev Brain Res. 62:1991;109-114.
22. Seeman P., Brozej N.H., Guan H-C, Bergeron C., Becker L.E., Reynolds G.P., Bird E.D., Riederer P., Jellinger K., Watanabe S., Tourtellotte W.W. Human brain dopamine receptors in children and aging adults. Synapse. 1:1987;399-404.
23. Tarazi F.I., Tomasini E.C., Baldessarini R.J. Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Dev Brain Res. 110:1998;227-233.
24. Tarazi F.I., Tomasini E.C., Baldessarini R.J. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study. Dev Neurosci. 21:1999;43-49.
25. Bolanos C.A., Garmsen G.M., Clair M.A., McDougall S.A. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat. Eur J Pharmacol. 317:1996;1-8.
26. Campbell J.O., Wood R.D., Spear L.P. Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiol Behav. 68:2000;487-493.
27. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology. 153:2000;31-43.
28. 3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology. 97:1989;175-178.
29. Acquas E., Carboni E., Leone P., Di Chiara G. SCH 23390 blocks drug-conditioned place preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology. 99:1989;151-155.
30. Fudala P.J., Teon K.W., Iwamoto E.T. Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol, Biochem Behav. 22:1985;237-241.
31. Jorenby D.E., Steinpreis R.E., Sherman J.E., Baker T.B. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology. 101:1990;533-538.
32. Clarke P.B.S., Fibiger H.C. Apparent absence of nicotine-induced conditioned place preference in rats. Psychopharmacology. 92:1987;84-88.
33. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effect. Recent progress and new issues. Prog Neurobiol. 56:1998;613-672.
34. Calcagnetti D.J., Schechter M.D. Nicotine place preference using the biased method of conditioning. Prog Neuro-Psychopharmacol Biol Psychiatry. 18:1994;925-933.
35. Fudala P.J., Iwamoto E.T. Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol, Biochem Behav. 25:1986;1041-1049.
36. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev. 94:1987;469-492.
37. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol. 14:1992;221-228.
38. Shoaib M., Stolerman I.P., Kumar R.C. Nicotine-induced place preference following prior nicotine exposure in rats. Psychopharmacology. 113:1994;445-452.
39. Hall F.S. Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences. Crit Rev Neurobiol. 12:1998;129-162.
40. Piazza P.V., Le Moal M. The role of stress in drug self-administration. TIPS. 19:1988;67-74.
41. Balfour D.J.K., Ridley D.L. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacol, Biochem Behav. 66:2000;79-85.
42. Cheeta S., Irvine E., File S.E. Social isolation modifies nicotine's effects in animal tests of anxiety. Br J Pharmacol. 132:2001;1389-1395.
43. Carr G.D., Fibiger H.C., Phillips A.G. Conditioned place preference as a measure of drug reward. Liebman J.M., Cooper S.J. The neuropharmacological basis of reward. 1989;264-319 Clarendon Press, Oxford.
44. File S.E., Cheeta S., Kenny P.J. Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur J Pharmacol. 393:2000;231-236.
45. Irwin E.E., Cheeta S., File S.E. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol. 10:1999;691-697.
46. Bauer R.H. Shuttlebox avoidance in Norway rats from infancy to maturity. Bull Psychon Soc. 15:1980;15-17.
47. Myslivecek J., Hassamannova J. Ontogeny of active avoidance in the rat: learning and memory. Dev Psychobiol. 12:1979;169-186.
48. Spear L.P., Brake S.C. Periadolescence: age dependence behavior and pharmacological responsivity in rats. Dev Psychobiol. 16:1983;83-109.
49. Clarke P.B.S., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol. 78:1983;329-337.
50. Ksir C. Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis. Psychopharmacology. 115:1994;105-109.
51. Morrison K.F., Stephenson J.A. The occurrence of tolerance to a central depressant effects of nicotine. Br J Pharmacol. 45:1972;151-156.
52. Benwell M.E.M., Balfour D.J.K. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol. 105:1992;849-856.
53. Miller D.K., Wilkins L.H., Bardo M.T., Crooks P.A., Dwoskin L.P. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology. 156:2001;469-476.
54. Glickman S.E., Schiff B.B. A biological theory of reinforcement. Psychol Rev. 74:1967;81-109.
55. Andersen S.L., Dumont N.L., Teicher M.H. Developmental differences in dopamine synthesis inhibition by (±)-7-OH-DPAT. Naunyn-Schmiedeberg's Arch Pharmacol. 356:1997;173-181.
56. Teicher M.H., Barber N.I., Gelbard H.A., Gallitano A.L., Campbell A., Marsh E., Baldessarini R.J. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology. 9:1993;147-156.
57. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22:1999;521-527.
58. Gardner E.L. The neurobiology and genetics of addiction: implications of the reward deficiency syndrome for therapeutic strategies in chemical dependency. Elster J. Addiction: entries and exits. 1999;57-119 Russell Sage Foundation, New York.
59. McBride W.J., Bodart B., Lumeng L., Li T-K Association between low contents of dopamine and serotonin in the nucleus accumbens and high alcohol preference. Alcohol Clin Exp Res. 19:1995;1420-1422.
60. Sziraki I., Lipovac M.N., Hashim A., Sershen H., Allen D., Cooper T., Czobar P., Lajtha A. Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats. Neurochem Res. 26:2001;609-617.
61. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev. 71:1991;155-234.